Vanda Pharmaceuticals
VNDA
VNDA
146 hedge funds and large institutions have $207M invested in Vanda Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 152 → 146 (-6)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
Holders
146
Holding in Top 10
–
Calls
$261K
Puts
$212K
Top Buyers
| 1 | +$3.47M | |
| 2 | +$2.44M | |
| 3 | +$1.3M | |
| 4 |
Millennium Management
New York
|
+$1.29M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.14M |
Top Sellers
| 1 | -$7.47M | |
| 2 | -$4.6M | |
| 3 | -$1.22M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.21M |
| 5 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$1.07M |